Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2022
Total Assets: $8.29B
Liabilities Breakdown FY2022
Total Liabilities: $2.49B
Asset Breakdown
Total Assets: $8.29B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $769.0M | 9.3% |
| Accounts Receivable | $643.0M | 7.8% |
| Inventory | $875.5M | 10.6% |
| Property, Plant & Equipment | $1.63B | 19.7% |
| Goodwill | $1.06B | 12.8% |
| Intangible Assets | $285.2M | 3.4% |
| Other Assets | $3.02B | 36.4% |
Liabilities Breakdown
Total Liabilities: $2.49B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $201.9M | 8.1% |
| Long-Term Debt | $596.3M | 24.0% |
| Other Liabilities | $1.69B | 67.9% |